查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1420983

甲狀腺疾病治療市場（疾病：甲狀腺功能減退症和甲狀腺功能亢進症）-全球產業分析、規模、佔有率、成長、趨勢和預測，2023-2031 年

Thyroid Gland Disorders Treatment Market (Disorders: Hypothyroidism and Hyperthyroidism) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 173 Pages | 商品交期: 2-10個工作天內

價格

甲狀腺疾病治療市場 - 報告範圍

TMR 關於全球甲狀腺疾病治療市場的報告研究了過去以及當前的成長趨勢和機會，以獲得 2023 年至 2031 年預測期內市場指標的寶貴見解。該報告提供了全球甲狀腺的收入2017-2031 年期間疾病治療市場，以2023 年為基準年，2031 年為預測年。該報告也提供了2023年至2031年全球甲狀腺疾病治療市場的年複合成長率（CAGR %）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解甲狀腺疾病治療市場。

市場概況
2023年市場價值 22億美元
2031 年市場價值 33億美元
CAGR 4.7%

該報告深入探討了全球甲狀腺疾病治療市場的競爭格局。全球甲狀腺疾病治療市場的主要參與者已經確定，並且每位參與者都根據各種屬性進行了分析。公司概述、財務狀況、最新發展和 SWOT 是本報告中介紹的全球甲狀腺疾病治療市場參與者的屬性。

目錄

第 1 章：執行摘要

第 2 章：假設與研究方法

第 3 章：執行摘要：全球市場

第 4 章：市場概述

  • 市場區隔
  • 概述
  • 市場動態
  • 2023-2031年全球市場分析與預測

第 5 章：關鍵見解

  • 管道分析
  • 甲狀腺疾病測試類型列表
  • 全球主要國家的疾病盛行率和發生率
  • COVID-19 大流行對該行業的影響

第 6 章：市場分析與預測：依序

  • 簡介和定義
  • 主要發現/進展
  • 市場價值預測：依序，2023-2031
    • 甲狀腺功能低下症
      • 左旋甲狀腺素
      • 碘塞羅寧
    • 甲狀腺功能亢進症
      • 咪唑
      • 丙哌啶
  • 市場吸引力：依無序分類

第 7 章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區，2023-2031
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力：按地區

第 8 章：北美市場分析與預測

第 9 章：歐洲市場分析與預測

第 10 章：亞太市場分析與預測

第 11 章：拉丁美洲市場分析與預測

第 12 章：中東和非洲市場分析與預測

第 13 章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 市佔率分析：依公司分類（2022 年）
  • 公司簡介
    • Merck KGaA
    • Pfizer, Inc.
    • Takeda Pharmaceutical Company Ltd.
    • Allergan
    • Sanofi SA
    • AbbVie Inc.
    • Lannet Company, Inc.
    • Aspen
Product Code: TMRGL3113

Thyroid Gland Disorders Treatment Market - Scope of Report

TMR's report on the global thyroid gland disorders treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global thyroid gland disorders treatment market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global thyroid gland disorders treatment market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the thyroid gland disorders treatment market.

Market Snapshot
Market Value in 2023US$ 2.2 Bn
Market Value in 2031US$ 3.3 Bn
CAGR4.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global thyroid gland disorders treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global thyroid gland disorders treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global thyroid gland disorders treatment market.

The report delves into the competitive landscape of the global thyroid gland disorders treatment market. Key players operating in the global thyroid gland disorders treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global thyroid gland disorders treatment market profiled in this report.

Key Questions Answered in Global thyroid gland disorders treatment Market Report:

  • What is the sales/revenue generated by thyroid gland disorders treatment across all regions during the forecast period?
  • What are the opportunities in the global thyroid gland disorders treatment market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Thyroid Gland Disorders Treatment Market - Research Objectives and Research Approach

The comprehensive report on the global thyroid gland disorders treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global thyroid gland disorders treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global thyroid gland disorders treatment market.

Table of Contents

1. Executive Summary

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Thyroid Gland Disorders Treatment Market

4. Market Overview

  • 4.1. Market Segmentation
    • 4.1.1. Segment Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Thyroid Gland Disorders Treatment Market Analysis and Forecast, 2023-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. List of Types of Thyroid Gland Disorder Tests
  • 5.3. Disorder Prevalence & Incidence Rate Globally With Key Countries
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Thyroid Gland Disorders Treatment Market Analysis and Forecast, by Disorder

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Disorder, 2023-2031
    • 6.3.1. Hypothyroidism
      • 6.3.1.1. Levothyroxine
      • 6.3.1.2. Liothyronine
    • 6.3.2. Hyperthyroidism
      • 6.3.2.1. Imidazole
      • 6.3.2.2. Propacil
  • 6.4. Market Attractiveness, by Disorder

7. Global Thyroid Gland Disorders Treatment Market Analysis and Forecast, by Region

  • 7.1. Key Findings
  • 7.2. Market Value Forecast, by Region, 2023-2031
    • 7.2.1. North America
    • 7.2.2. Europe
    • 7.2.3. Asia Pacific
    • 7.2.4. Latin America
    • 7.2.5. Middle East & Africa
  • 7.3. Market Attractiveness, by Region

8. North America Thyroid Gland Disorders Treatment Market Analysis and Forecast

  • 8.1. Introduction
    • 8.1.1. Key Findings
  • 8.2. Market Value Forecast, by Disorder, 2023-2031
    • 8.2.1. Hypothyroidism
      • 8.2.1.1. Levothyroxine
      • 8.2.1.2. Liothyronine
    • 8.2.2. Hyperthyroidism
      • 8.2.2.1. Imidazole
      • 8.2.2.2. Propacil
  • 8.3. Market Attractiveness, by Disorder
  • 8.4. Market Value Forecast, by Country, 2023-2031
    • 8.4.1. U.S.
    • 8.4.2. Canada
  • 8.5. Market Attractiveness Analysis
    • 8.5.1. By Disorder
    • 8.5.2. By Country

9. Europe Thyroid Gland Disorders Treatment Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast, by Disorder, 2023-2031
    • 9.2.1. Hypothyroidism
      • 9.2.1.1. Levothyroxine
      • 9.2.1.2. Liothyronine
    • 9.2.2. Hyperthyroidism
      • 9.2.2.1. Imidazole
      • 9.2.2.2. Propacil
  • 9.3. Market Attractiveness, by Disorder
  • 9.4. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 9.4.1. Germany
    • 9.4.2. U.K.
    • 9.4.3. France
    • 9.4.4. Italy
    • 9.4.5. Spain
    • 9.4.6. Rest of Europe
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Disorder
    • 9.5.2. By Country/Sub-region

10. Asia Pacific Thyroid Gland Disorders Treatment Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Disorder, 2023-2031
    • 10.2.1. Hypothyroidism
      • 10.2.1.1. Levothyroxine
      • 10.2.1.2. Liothyronine
    • 10.2.2. Hyperthyroidism
      • 10.2.2.1. Imidazole
      • 10.2.2.2. Propacil
  • 10.3. Market Attractiveness, by Disorder
  • 10.4. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 10.4.1. China
    • 10.4.2. Japan
    • 10.4.3. India
    • 10.4.4. Australia & New Zealand
    • 10.4.5. Rest of Asia Pacific
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Disorder
    • 10.5.2. By Country/Sub-region

11. Latin America Thyroid Gland Disorders Treatment Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Disorder, 2023-2031
    • 11.2.1. Hypothyroidism
      • 11.2.1.1. Levothyroxine
      • 11.2.1.2. Liothyronine
    • 11.2.2. Hyperthyroidism
      • 11.2.2.1. Imidazole
      • 11.2.2.2. Propacil
  • 11.3. Market Attractiveness, by Disorder
  • 11.4. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 11.4.1. Brazil
    • 11.4.2. Mexico
    • 11.4.3. Rest of Latin America
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Disorder
    • 11.5.2. By Country/Sub-region

12. Middle East & Africa Thyroid Gland Disorders Treatment Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Disorder, 2023-2031
    • 12.2.1. Hypothyroidism
      • 12.2.1.1. Levothyroxine
      • 12.2.1.2. Liothyronine
    • 12.2.2. Hyperthyroidism
      • 12.2.2.1. Imidazole
      • 12.2.2.2. Propacil
  • 12.3. Market Attractiveness, by Disorder
  • 12.4. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 12.4.1. GCC Countries
    • 12.4.2. South Africa
    • 12.4.3. Rest of Middle East & Africa
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Disorder
    • 12.5.2. By Country/Sub-region

13. Competition Landscape

  • 13.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 13.2. Market Share Analysis, by Company (2022)
  • 13.3. Company Profiles
    • 13.3.1. Merck KGaA
      • 13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.1.2. Disorder Portfolio
      • 13.3.1.3. Financial Overview
      • 13.3.1.4. SWOT Analysis
      • 13.3.1.5. Strategic Overview
    • 13.3.2. Pfizer, Inc.
      • 13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.2.2. Disorder Portfolio
      • 13.3.2.3. Financial Overview
      • 13.3.2.4. SWOT Analysis
      • 13.3.2.5. Strategic Overview
    • 13.3.3. Takeda Pharmaceutical Company Ltd.
      • 13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.3.2. Disorder Portfolio
      • 13.3.3.3. Financial Overview
      • 13.3.3.4. SWOT Analysis
      • 13.3.3.5. Strategic Overview
    • 13.3.4. Allergan
      • 13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.4.2. Disorder Portfolio
      • 13.3.4.3. Financial Overview
      • 13.3.4.4. SWOT Analysis
      • 13.3.4.5. Strategic Overview
    • 13.3.5. Sanofi S.A.
      • 13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.5.2. Disorder Portfolio
      • 13.3.5.3. Financial Overview
      • 13.3.5.4. SWOT Analysis
      • 13.3.5.5. Strategic Overview
    • 13.3.6. AbbVie Inc.
      • 13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.6.2. Disorder Portfolio
      • 13.3.6.3. Financial Overview
      • 13.3.6.4. SWOT Analysis
      • 13.3.6.5. Strategic Overview
    • 13.3.7. Lannet Company, Inc.
      • 13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.7.2. Disorder Portfolio
      • 13.3.7.3. Financial Overview
      • 13.3.7.4. SWOT Analysis
      • 13.3.7.5. Strategic Overview
    • 13.3.8. Aspen
      • 13.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.8.2. Disorder Portfolio
      • 13.3.8.3. Financial Overview
      • 13.3.8.4. SWOT Analysis
      • 13.3.8.5. Strategic Overview

List of Tables

  • Table 1: Global Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Disorder, 2023-2031
  • Table 2: Global Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Region, 2023-2031
  • Table 3: North America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Country, 2023-2031
  • Table 4: North America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Disorder, 2023-2031
  • Table 5: Europe Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 6: Europe Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Disorder, 2023-2031
  • Table 7: Asia Pacific Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 8: Asia Pacific Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Disorder, 2023-2031
  • Table 9: Latin America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 10: Latin America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Disorder, 2023-2031
  • Table 11: Middle East & Africa Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2032-2031
  • Table 12: Middle East & Africa Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Disorder, 2023-2031

List of Figures

  • Figure 1: Global Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 2: Global Thyroid Gland Disorders Treatment Market Value Share, by Disorder, 2022
  • Figure 3: Global Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorder, 2022 and 2031
  • Figure 4: Global Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorder, 2023-2031
  • Figure 5: Global Thyroid Gland Disorders Treatment Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 6: Global Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 7: North America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 8: North America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 9: North America Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 10: North America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorder, 2022 and 2031
  • Figure 11: North America Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorder, 2023-2031
  • Figure 12: Europe Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 13: Europe Thyroid Gland Disorders Treatment Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 14: Europe Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 15: Europe Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorder, 2022 and 2031
  • Figure 16: Europe America Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorder, 2023-2031
  • Figure 17: Asia Pacific Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 18: Asia Pacific Thyroid Gland Disorders Treatment Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 19: Asia Pacific Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 20: Asia Pacific Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorder, 2022 and 2031
  • Figure 21: Asia Pacific America Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorder, 2023-2031
  • Figure 22: Latin America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 23: Latin America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 24: Latin America Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 25: Latin America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorder, 2022 and 2031
  • Figure 26: Latin America Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorder, 2023-2031
  • Figure 27: Middle East & Africa Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 28: Middle East & Africa Thyroid Gland Disorders Treatment Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 29: Middle East & Africa Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 30: Middle East & Africa America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorder, 2023-2031
  • Figure 31: Middle East & Africa America Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorder, 2023-2031
  • Figure 32: Global Thyroid Gland Disorders Treatment Market Share Analysis, by Company (2022)